⌘K
t
RIT Capital Partners PLC announced its preliminary unaudited diluted Net Asset Value (NAV) as at 31 December 2025 was 2,921p per ordinary share (30 November 2025: 2,899p). This represented a +0.8% total return for December 2025 and a +13.5% NAV per share total return for the year. The company also bought back £13.4m, or approximately 593,000 shares, in December, bringing the total share capital repurchased for the year to 3% at a value of £89.0m.
| Date | 5 Feb 2026 |
| Time | 07:00:08 |
| Category | Corporate updates |
| ID | 7717R |
RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)
5 February 2026
December 2025 Preliminary Unaudited Net Asset Value
RIT Capital Partners plc ("RIT") announces that its preliminary unaudited diluted NAV as at 31 December 2025 (with debt at fair value) was 2,921p per £1 ordinary share (30 November 2025: 2,899p). This represents a +0.8% total return for the month, outperforming the ACWI (50% £) at +0.1%.
The preliminary 31 December 2025 NAV is equivalent to a NAV per share total return for the year of +13.5%, with double-digit returns across all three investment pillars (Quoted Equities, Private Investments and Uncorrelated Strategies). Our annualised NAV per share total return since inception is +10.6%, underscoring our commitment to delivering healthy, long-term returns for our shareholders.
As is customary at this point in our year-end process, the preliminary NAV and associated performance numbers for 2025 are estimates, and subject to potential adjustment and audit. Full details will be included in the 2025 Annual Report and Accounts, which is expected to be published by early March 2026.
December 2025 Performance Highlights
RIT delivered resilient performance, demonstrating the benefits of our diversified global portfolio. Performance was led by Private Investments and Uncorrelated Strategies which contributed positively to NAV. Quoted Equities detracted modestly during the month, while the continued strengthening of sterling against the US dollar resulted in a negative translation effect on our global portfolio.
|
- |
In Quoted Equities, weakness in technology and biotech stocks was partially offset by strong performance in our quality theme and emerging markets related holdings. |
|
- |
Private Investments delivered positive returns, helped by an uplift in December valuations of our direct holdings. As of 31 December 2025, more than 99% of our private funds were held at 30 September 2025 reported valuations and all private direct holdings were valued as at 31 December 2025, in line with our valuation policy. |
|
- |
Uncorrelated Strategies, which acts as a steady diversifier of returns, contributed positively to our NAV, supported by gold and credit. |
|
- |
We continued our share buyback programme, buying back £13.4m or approximately 593,000 shares in December, adding an estimated +9bps accretion to NAV. As at 31 December 2025, the total share capital repurchased through buybacks since the start of the year amounted to 3% at a total value of £89.0m. |
For more information:
J. Rothschild Capital Management (Manager):
T: 020 7647 8565
E: investorrelations@ritcap.co.uk
Deutsche Numis (Joint broker):
Nathan Brown, Vicki Paine
T: 020 7260 1000
JP Morgan Cazenove Limited (Joint broker):
William Simmonds
T: 020 3493 8000
Brunswick Group (Media enquiries):
Nick Cosgrove, Peter Hesse
T: 020 7404 5959
E: RIT@BrunswickGroup.com